Category: Professional Posters
Purpose: The role of the research pharmacist has significantly evolved over time. Investigational drug services vary from each hospital and usually reflects the needs of the hospital. Traditional research pharmacy services centers on dispensing investigational drug products and maintaining accountability records, with interactions with participants being limited or nonexistent.
The aim of this survey was to gain perspectives and information on current and future IDS clinical services to begin discussing the expansion of research pharmacy clinical services.
Methods: A survey was created and distributed to select research pharmacists via email. A total of 9 surveys were completed.
Results: 55.6% of respondents (5 of 9) answered 'Yes' when asked if their pharmacy practice provided clinical services. Of the respondents that answered yes, responses to the type of clinical services provided included teaching/presentations, medication reconciliation, protocol writing, consultations/training, and laboratory monitoring. Respondents were asked how often clinical services were performed, 2 respondents answered none (33%), 2 respondents answered 1-2 days (33%), 1 respondent answered 3-4 days (16%), and 1 respondent answered daily (16%). When asked what clinical services they would like to see implemented, the majority of responses noted patient counseling/education and medication reconciliation.
Conclusion: The American Society of Health-System Pharmacists (ASHP) recently published guidelines for the management of investigational drug products. These guidelines offer research pharmacies general guidance on facilitating clinical trials. There are many areas and opportunities available for research pharmacies to play a more active role with research participants. By defining research pharmacy clinical services and providing guidance on how to implement these services, research pharmacies can expand patient care services.